5.40
Abeona Therapeutics Inc (ABEO) 最新ニュース
(ABEO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 earnings call transcript - MSN
ABEO SEC FilingsAbeona Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
JPMorgan Chase Trims Stake in Abeona Therapeutics - National Today
Abeona Therapeutics Stock Price Crosses 50-Day Moving Average - National Today
JPMorgan Chase & Co. Trims Position in Abeona Therapeutics Inc. $ABEO - MarketBeat
Aberdeen Group Invests $3.25M in Abeona Therapeutics - National Today
Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
ABEO Should I Buy - Intellectia AI
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair - The Globe and Mail
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors - Sahm
Abeona Therapeutics names Keith Goldan to board of directors By Investing.com - Investing.com Canada
Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo Finance UK
Abeona Therapeutics names Keith Goldan to board of directors - Investing.com
Abeona Therapeutics Announces Appointment of Keith A. Goldan to its Board of Directors - Bitget
Abeona Therapeutics Appoints Keith A. Goldan to Board - National Today
Abeona Therapeutics Appoints Keith A. Goldan to Board of Directors and Audit Committee to Support Commercial Growth - Minichart
[Form 4] ABEONA THERAPEUTICS INC. Insider Trading Activity - Stock Titan
Abeona Therapeutics (ABEO) director Form 3 lists no stock trades - Stock Titan
Keith A. Goldan appointed to Abeona Therapeutics' board, named Audit Committee Chair - TradingView — Track All Markets
Keith Goldan joins Abeona Therapeutics (ABEO) board as independent audit chair - Stock Titan
Biotech Abeona taps veteran CFO Keith Goldan to oversee audits - Stock Titan
Abeona Therapeutics (ABEO) — 3.01M shares disclosed by Funicular/Cable Car (5.3%) - Stock Titan
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
Panic Selling: Should I set a stop loss on Abeona Therapeutics Inc2026 Chart Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York - Sahm
ABEO PE Ratio & Valuation, Is ABEO Overvalued - Intellectia AI
New York hospital joins Abeona network for blistering skin therapy - Stock Titan
ABEO Technical Analysis & Stock Price Forecast - Intellectia AI
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock By Investing.com - Investing.com Australia
Insider Sell: Vishwas Seshadri Sells 29,985 Shares of Abeona The - GuruFocus
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock - Investing.com
Abeona (ABEO) CEO sells 29,985 shares under Rule 10b5-1 plan - stocktitan.net
ABEO (NASDAQ: ABEO) Form 144: 29,985 restricted shares proposed sale - Stock Titan
Daniel Kaufman files Schedule 13G — Abeona (NASDAQ: ABEO) 5.16% stake - Stock Titan
Vanguard disaggregates holdings; ABEO ownership shown as 0 (ABEO) - stocktitan.net
Meme Stocks: Does Abeona Therapeutics Inc have strong EBITDA margins2026 Earnings Surprises & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings - MarketBeat
Oppenheimer Maintains Outperform on Abeona Therapeutics (ABEO) PT $22 March 2026 - Meyka
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules - The Globe and Mail
Abeona Therapeutics Adopts Third Amended and Restated Bylaws Effective March 16, 2026 - Minichart
Form 8K Abeona Therapeutics Inc For: 20 March By Investing.com - Investing.com Australia
Form 8K Abeona Therapeutics Inc For: 20 March - Investing.com
Abeona (NASDAQ: ABEO) tightens bylaws on meetings and director nominations - Stock Titan
Abeona Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Abeona Therapeutics Earnings Notes - Trefis
大文字化:
|
ボリューム (24 時間):